ATR
ATR is a vital serine/threonine kinase that acts as the primary sensor of replication stress and single-stranded DNA breaks. Unlike ATM, which focuses on double-strand breaks, ATR is essential for the survival of every dividing cell, monitoring the integrity of DNA replication and stabilizing stalled forks. Mutations in the ATR pathway lead to severe genomic instability syndromes like Seckel syndrome, while pharmacological inhibition of ATR is an emerging strategy in targeted cancer therapy.
Key Takeaways
- •ATR is a master regulator of the DNA damage response, specifically sensing replication stress and single-strand breaks.
- •It coordinates cell cycle arrest and DNA repair to maintain genomic stability and prevent cancer.
- •Mutations in ATR or its pathway components can lead to Seckel syndrome and increased cancer susceptibility.
- •ATR is a major therapeutic target in oncology, with inhibitors used to sensitize tumors to DNA-damaging agents.
Basic Information
- Gene Symbol
- ATR
- Full Name
- ATR Serine/Threonine Kinase
- Also Known As
- FRP1SCKL1
- Location
- 3q23
- Protein Type
- Ser/Thr kinase
- Protein Family
- PI3K-related kinase (PIKK)
Related Isoforms
Key SNPs
Associated with Seckel syndrome; leads to severely reduced ATR protein levels.
Common variant studied in cancer susceptibility and response to DNA-damaging therapies.
Occurs at a key autophosphorylation site; may influence ATR activation efficiency.
Studied as a tag SNP for ATR expression levels in various population studies.
Located in regulatory region; may affect mRNA stability or miRNA binding.
Rare variant with potential functional impact on protein folding or stability.
Overview
ATR (Ataxia Telangiectasia and Rad3-related) is a large kinase that functions as the central coordinator of the cellular response to replication stress and DNA single-strand breaks. While its relative ATM primarily handles double-strand breaks, ATR is essential for the viability of every dividing cell because it monitors the integrity of DNA replication.
When replication forks stall or DNA is damaged, regions of single-stranded DNA (ssDNA) are exposed and coated by RPA. ATR, in complex with ATRIP, is recruited to these sites, where it triggers a signaling cascade that halts the cell cycle and facilitates repair.
Conceptual Model
A simplified mental model for the pathway:
Core Health Impacts
- • Genomic stability: Protects genomic stability by preventing replication fork collapse
- • Cancer prevention: Prevents the accumulation of mutations that lead to cancer
- • Repair coordination: Coordinates DNA repair with cell cycle progression
- • Stem cell health: Supports telomere maintenance and stem cell health
- • Neurodevelopment: Essential for proper neurodevelopment and growth
Protein Domains
HEAT Repeats
N-terminal alpha-helical repeats that provide a large surface for protein-protein interactions and scaffolding.
FAT/FATC
Conserved domains that flank the kinase domain, essential for structural integrity and regulation of activity.
Kinase Domain
C-terminal catalytic domain that phosphorylates substrates on Serine/Threonine residues followed by Glutamine (SQ/TQ motifs).
Upstream Regulators
RPA-ssDNA Activator
Single-stranded DNA coated with Replication Protein A; the primary signal of replication stress.
ATRIP Activator
Essential partner protein that recruits ATR to RPA-coated ssDNA at stalled replication forks.
TOPBP1 Activator
Recruited to stalled forks by the 9-1-1 complex; directly stimulates ATR catalytic activity.
ETAA1 Activator
Direct activator of ATR that functions independently of TOPBP1, particularly during replication.
9-1-1 Complex Activator
Heterotrimeric clamp (RAD9-RAD1-HUS1) that recruits TOPBP1 to the sites of damage.
RAD17-RFC Activator
Clamp loader that deposits the 9-1-1 complex onto DNA at primer-template junctions.
Downstream Targets
Chk1 Activates
Primary downstream effector; phosphorylated at Ser317/Ser345 to trigger cell cycle arrest.
p53 Activates
ATR phosphorylates p53 at Ser15, promoting its stabilization and transcriptional activity.
H2AX Activates
Phosphorylates Ser139 (γ-H2AX) at stalled replication forks to organize repair foci.
MCM2 Activates
Phosphorylation by ATR regulates replication fork speed and prevents excessive origin firing.
BRCA1 Activates
Substrate involved in homologous recombination and DNA cross-link repair.
WRN Helicase Activates
ATR phosphorylation supports WRN function in maintaining replication fork stability.
Role in Aging
ATR is a fundamental guardian against genomic instability, one of the primary hallmarks of aging. By managing replication stress and ensuring high-fidelity DNA duplication, ATR prevents the accumulation of damage that drives cellular senescence and functional decline.
Stem Cell Maintenance
ATR is critical for the survival of rapidly dividing stem cell populations. Deficiency leads to stem cell exhaustion and progeroid (premature aging) phenotypes in animal models.
Replication Stress
Chronic replication stress is a major driver of cellular senescence. ATR resolves stalled forks, preventing them from collapsing into permanent double-strand breaks.
Telomere Protection
ATR is involved in telomere maintenance and the Alternative Lengthening of Telomeres (ALT) pathway, helping to preserve chromosome end integrity over time.
DNA Repair Efficiency
High ATR pathway efficiency is correlated with longevity across species, reflecting the importance of robust DNA damage checkpoints for long-term health.
Senescence Prevention
By facilitating repair before cell division, ATR prevents "mitotic catastrophe" and the subsequent induction of the Senescence-Associated Secretory Phenotype (SASP).
Mitohormesis
Mild, transient activation of the ATR pathway (e.g., via low-dose stressors) may stimulate adaptive DNA repair capacity, a process known as hormesis.
Disorders & Diseases
Cancer
ATR is often dysregulated in cancers. Somatic mutations are common in microsatellite unstable (MSI) tumors. Furthermore, loss of other DDR components (like ATM or p53) makes tumors highly dependent on ATR for survival.
Seckel Syndrome
A rare autosomal recessive disorder caused by biallelic mutations in ATR or its partners. It is characterized by severe intrauterine growth retardation, microcephaly, and a "bird-like" facial appearance.
Lynch Syndrome (MSI)
Somatic mutations in ATR are frequently found in colorectal and endometrial cancers associated with Lynch syndrome, particularly at a poly-A tract within the ATR gene.
Genomic Instability Syndromes
Broadly, defects in the ATR-Chk1 axis contribute to various conditions marked by chromosome fragility and an increased risk of hematopoietic failure and malignancy.
Interventions
Supplements
Supports overall DNA repair efficiency; deficiency is linked to increased genomic instability.
Antioxidant that reduces oxidative DNA damage, potentially lowering the basal load on ATR.
Sirtuin activator that may cross-talk with DNA damage response pathways to support genomic stability.
Mitochondrial support that reduces reactive oxygen species, protecting against mitochondrial DNA damage.
Lifestyle
Essential, as UV light creates bulky DNA lesions and stalled forks that require ATR for repair.
Induces mild transient oxidative stress that can upregulate DNA repair systems (hormesis).
ATR expression and activity are influenced by the clock; sleep hygiene supports DNA repair cycles.
Provides micronutrients that serve as cofactors for DNA repair enzymes and neutralize genotoxic agents.
Medicines
Clinical stage oncology drugs (e.g., Berzosertib, Ceralasertib) used to sensitize tumors to DNA damage.
Synthetically lethal with DDR defects; sometimes combined with ATR inhibitors in clinical trials.
Creates bulky adducts that ATR must resolve; ATR inhibition makes cells hyper-sensitive to these agents.
Lab Tests & Biomarkers
Genetic Testing
Full gene analysis for diagnosis of Seckel syndrome or somatic cancer profiling.
Determining microsatellite instability status, often linked to ATR mutations in tumors.
Activity Markers
The gold-standard marker for ATR kinase activity in cellular assays.
Indicates sites of DNA damage and stalled forks where ATR is active.
Autophosphorylation site used as a direct readout of ATR activation.
Genotoxicity
Measures chromosome fragments that fail to incorporate into nuclei, a sign of DDR failure.
Single-cell gel electrophoresis to quantify the extent of DNA damage.
Hormonal Interactions
Estrogen Contextual Stressor
Can drive rapid proliferation and replication stress in sensitive tissues, increasing ATR dependency.
Androgens Repair Modulator
Influence the expression of several DNA repair genes, including components of the ATR pathway.
IGF-1 Growth Stimulator
Drives cell cycle progression; high levels increase the "replication load" that ATR must monitor.
Cortisol Repair Suppressor
Chronic glucocorticoid elevation can impair the efficiency of the cellular DNA damage response.
Melatonin Protective Agent
Provides antioxidant protection and may support the expression of DNA repair proteins during sleep.
Deep Dive
Network Diagrams
ATR Activation Pathway
Replication Fork Stability
The ATR Activation Cascade: From Sensing to Signaling
The activation of ATR is a highly coordinated process that ensures the cell only halts its cycle when DNA integrity is truly at risk. The primary trigger is single-stranded DNA (ssDNA), which is rarely present in healthy, non-replicating cells but accumulates when DNA polymerase stalls.
- Recruitment: Exposed ssDNA is immediately coated by RPA. The ATRIP protein binds directly to RPA, bringing ATR into proximity with the damage. This “recruitment” phase is necessary but not sufficient for full kinase activity.
- Activation: To achieve high catalytic output, ATR must interact with specific activators like TOPBP1 or ETAA1. TOPBP1 is recruited by the 9-1-1 complex, which is loaded at the junction between single-stranded and double-stranded DNA. This precise spatial arrangement ensures ATR is only fully active at the exact site of replication interference.
Maintaining the Fork: Why ATR is Essential for Life
Unlike many other DNA repair genes, ATR is essential for cellular viability. This is because replication forks encounter “obstacles” (like DNA lesions, secondary structures, or protein-DNA complexes) thousands of times during every S-phase.
Without ATR, these stalled forks would “collapse”—a catastrophic event where the replication machinery falls off and the DNA breaks. ATR prevents collapse by stabilizing the replisome and inhibiting the firing of nearby “late” origins, allowing time for the obstacle to be cleared and replication to resume safely.
Synthetic Lethality: ATR as a Therapeutic Target
In oncology, ATR is a prime target for synthetic lethality. Many tumors have lost the G1 checkpoint (often via p53 mutation) or the ATM-mediated response to double-strand breaks. These cancer cells become “addicted” to the ATR-Chk1 pathway to manage the high levels of replication stress inherent in rapid tumor growth.
By inhibiting ATR, clinicians can selectively drive cancer cells into “mitotic catastrophe” while relatively sparing healthy, non-cycling cells. This strategy is currently being tested in numerous clinical trials, often in combination with PARP inhibitors or traditional chemotherapy.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
Comprehensive review establishing ATR as the primary kinase responding to replication interference.
Identified ATRIP as the crucial adaptor that tethers ATR to RPA-coated single-stranded DNA.
Mechanistic study showing how TOPBP1 activates the ATR-ATRIP complex at sites of damage.
Translational review of the ATR pathway and the development of ATR inhibitors for cancer therapy.
Early evidence linking ATR to the p53 tumor suppressor pathway during the UV-induced stress response.
Detailed analysis of clinical progress and challenges for ATR inhibitors in oncology.